Friday, June 27, 2014
1-2 PM Eastern Time
The Growing Crisis in Cancer Care
Guests: Jimmy Lin, William Maples, Noah Zanville, and Trish Silber
What are the odds you’ll get cancer in the next 20 years?
Are there enough doctors, nurses, and resources to meet the cancer challenge?
What will cancer cost families, private institutions and the public?
The World Health Organization’s World Cancer Report estimates new cancer cases will rise from 14 million a year to nearly 22 million a year within the next two decades. In theU.S., the American Society of Clinical Oncology predicts cancer will become the leading cause of death, surpassing heart disease, in 16 years. The number ofU.S.cases is expected to increase nearly 45 percent by 2030, from 1.6 million cases a year to 2.3 million a year. Aging populations is a big factor in the increase, and while there have been some treatment breakthroughs, costs are rising and the influx of new patients will challenge hospitals and physicians. Join the conversation to learn more and hear some ideas for solutions.
Jimmy Lin, MD, PhD, MHS,is a 2012 TED Fellow and Founder and President of Rare Genomics Institute, a cancer researcher, and pioneer of cancer genome sequencing. RGI is the world's first platform to enable communities to leverage cutting-edge biotechnology to advance understanding of rare diseases. Partnering with top medical institutions, such as Harvard, Yale, Johns Hopkins, and Stanford, RGI helps custom design personalized research projects for diseases so rare that no organization exists to help. Previously, Dr. Lin was a medical school faculty member at the Washington University in St. Louis and, while at Johns Hopkins, led the computational analysis of the first ever exome sequencing studies for any human disease. He has numerous publications in Science, Nature Genetics, Nature Biotechnology, and Cell and has been featured in Forbes, Bloomberg Businessweek, Wall Street Journal, Washington Post, BBC, TIME, CNN, and the Huffington Post.
William J. Maples, MD is senior vice president and Medical Director of Quality at Mission Health in Asheville, N.C. He was previously chair of the Quality Oversight Committee at Mayo Clinic in Jacksonville, FL, chair of the Service Excellence Committee and Vice-Chair of the Quality Committee for Mayo Clinic enterprise. Dr. Maples received his medical degree from the University of Wisconsin and completed his residency and fellowship in oncology at Mayo Graduate School of Medicine in Rochester,MN and was an associate professor of oncology at Mayo Medical School. He was designated Mayo Clinic Jacksonville Teacher of the Year, Hematology/Oncology, in 2000 and 2001. In 2003, he was honored by his peers who selected him for the Distinguished Mayo Clinician Award in recognition of outstanding clinical competence. He was chair of the Melanoma Disease Group and chair of the Sarcoma Treatment Group in Jacksonville and president of the North American Neuroendocrine Tumor Society. He was also co-director of the Communication in Healthcare Program and has been working the Center for Global Health and Medical Diplomacy at University of North Florida to promote relationship-centered healthcare.
Noah Zanville, BSN, RN, BA, is 4th year PhD student in Clinical Nursing Science at Indiana University School of Nursing. His research focuses on a growing problem for cancer patients – the painful nerve damage caused by chemotherapy. Measuring nerve damage is critical to managing symptoms, but simple, accurate tools for doing this remain elusive. Partnering with researchers at the Department of Pharmacology at the Indiana University of School of Medicine and the Indiana Center for Vascular Biology and Medicine, Noah is doing research on whether a method for testing nerve damage used in diabetes research can be adapted for cancer patients. Noah is a current National Cancer Institute Behavioral Oncology and Cancer Control training fellow and former National Institutes of Health Behavioral Nursing Research fellow. He is a member of Sigma Theta Tau International the Oncology Nursing Society, the National Comprehensive Cancer Network, and the Indiana University Simon Cancer Center: Cancer Prevention and Control Group.
Trish Silber is president of Aliniad Consulting Partners, Inc., a Washington D.C.-based consulting firm focused on strategy, leadership, and organizational change. Her expertise is in executive coaching and in leading system-wide strategy and change efforts from a complexity perspective. She has over 25 years of experience consulting to businesses, government and non-profits. Trish earned an MBA from Santa Clara University and a BA in behavioral psychology from Connecticut College. She served on the faculty of the George Washington University graduate program on leadership coaching from 2001 to 2006. Trish is a former board member for Plexus Institute and currently serves on the board of the National Environmental Education Foundation and on the Advisory Council of The Leadership Sanctuary. She is a TED Fellow coach and participated in the 2012 and 2013 SupporTED Collaboratoria.